Abstract
To assess a potential diagnostic and therapeutic biomarker for age-related macular degeneration (AMD), we sequenced the complement factor I gene (CFI) in 2266 individuals with AMD and 1400 without, identifying 231 individuals with rare genetic variants. We evaluated the functional impact by measuring circulating serum factor I (FI) protein levels in individuals with and without rare CFI variants. The burden of very rare (frequency
Original language | English |
---|---|
Pages (from-to) | 3861-70 |
Journal | Human Molecular Genetics |
Volume | 24 |
Issue number | 13 |
DOIs | |
Publication status | Published - 2015 |